[1]
Martins, A.L.M. et al. 2021. AVERAGE SURVIVAL OF PATIENTS TREATED ON STAGE I AND CLINICALLY N0 BREAST CANCER, FROM JANUARY 2010 TO DECEMBER 2019 SUBMITTED TO AXILLARY LYMPHONODECTOMY OR SENTINEL LYMPH NODE. Mastology. 31, (ago. 2021), 5.